Wells Fargo & Company »

Aurinia Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 162k 8.99
2023-09-30 $1.5M 192k 7.77
2023-06-30 $2.1M 213k 9.68
2022-12-31 $659k 153k 4.32
2022-09-30 $2.7M 349k 7.69
2022-06-30 $3.8M 379k 10.00
2022-03-31 $5.7M 481k 11.92
2021-12-31 $11M 497k 22.78
2021-09-30 $13M 579k 22.13
2021-06-30 $10M 788k 12.96
2021-03-31 $9.9M 764k 12.99
2020-12-31 $9.2M 667k 13.83
2020-09-30 $5.6M 378k 14.73
2020-06-30 $2.9M 177k 16.25
2020-03-31 $6.0M 416k 14.51
2019-12-31 $1.6M 80k 20.26
2019-09-30 $416k 78k 5.33
2019-06-30 $513k 78k 6.58
2019-03-31 $374k 58k 6.50
2018-12-31 $6.0k 832 7.21
2018-09-30 $114k 17k 6.62
2018-06-30 $108k 19k 5.61
2018-03-31 $126k 24k 5.21
2017-12-31 $89k 20k 4.52
2017-06-30 $1.0k 200 5.00